Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Maxim Group Starts Adocia (ADOC:FP) (ADOCY) at Buy
-
Draganfly closes $25 million registered direct offering
-
Draganfly Announces Closing of US$25.0 Million Registered Direct Offering
-
Maxim Group LLC Expands Equity Sales and Trading with Strategic Hire of Michael Chrisman
-
OceanPal prices upsized $18 million public offering at $1.64 per unit
-
OceanPal Inc. Announces Pricing of Upsized US$18.0 Million Public Offering
-
NioCorp closes $45 million public offering of common shares
-
NioCorp Announces Closing of $45.0 Million Public Offering of Common Shares
-
Draganfly raises $25 million through registered direct offering
-
Draganfly Announces Pricing of US$25.0 Million Registered Direct Offering
-
Maxim Group Starts Akari Therapeutics (AKTX) at Buy
-
Citius Oncology closes $9 million public offering
-
Citius Oncology Announces Closing of $9.0 Million Public Offering
-
Citius Oncology Announces Closing of $9.0 Million Public Offering
-
NioCorp prices $45 million stock offering at $3.25 per share
-
NioCorp Announces Pricing of $45.0 Million Public Offering of Common Shares
-
AmpliTech Group Reports Preliminary Q2 2025 Revenue of Nearly $11 Million; 5G ORAN Division Drives 75% of Sales
-
RYVYL closes $6 million public offering of shares and warrants
-
RYVYL Announces Closing of $6.0 Million Public Offering
-
NioCorp commences proposed public offering of common shares
-
NioCorp Announces Commencement of Proposed Public Offering of Common Shares
-
Citius Oncology prices $9 million public offering at $1.32 per share
-
Citius Oncology Announces Pricing of $9.0 Million Public Offering
-
AmpliTech Group added to four Russell indexes effective June 30
-
AmpliTech Group Joins Four Key Russell Indexes, Marking a Significant Milestone in Capital Market Recognition
-
Rani Therapeutics prices $3 million registered direct offering at $0.40 per share
-
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering
-
RYVYL prices $6 million public offering at $0.39 per share
-
RYVYL Announces Pricing of $6.0 Million Public Offering
-
AmpliTech supplies cryogenic amplifiers for quantum computing systems
-
AmpliTech’s Cryogenic LNAs Power the Future of Quantum Computing and AI
-
SEALSQ prices $60 million registered direct offering at $4.00 per share
-
SEALSQ Announces Pricing of $60.0 Million Registered Direct Offering
-
LQWD Announces Closing of Brokered Portion of Financing for Gross Proceeds of C$10 Million
-
AmpliTech Group Poised to Benefit from New Federal “One Big Beautiful Bill” Supporting Private 5G and ORAN Rollouts
-
IceCure Medical starts $10 million rights offering
-
IceCure Announces Commencement of Rights Offering
-
Llama Group SA Announces the Successful Completion of Its Capital Increase via a Private Placement for an Amount of € 1.000.000
-
Interactive Strength Inc. (Nasdaq: TRNR) Receives "Buy" Rating and $15 Price Target in Maxim Group Research Initiation
-
LQWD Secures C$12.3 Million Financing Led by Polar Asset Management to Advance Bitcoin Lightning Strategy
-
AmpliTech Group receives $2.9 million in follow-on 5G orders
-
AmpliTech Group’s 5G Division Receives $2.9 Million Follow-On Orders As Part Of $40M LOI For 5G ORAN Radio Products From Tier 1 MNO
-
GenSight Biologics Announces the Closing of the Company’s c. €4 Million Private Placement
-
Llama Group SA Announces a Capital Increase via a Private Placement of € 1.000.000
-
NMP Acquisition Corp. Announces Closing of $100 Million Initial Public Offering
-
Maxim Group Resumes Graham Corporation (GHM) at Buy
-
DDC Enterprise Announces Closing of its $528 Million Financing to Advance Bitcoin Treasury Strategy
-
Maxim Group Starts Fossil (FOSL) at Buy
-
Maxim Group Starts Alliance Entertainment Holding Corp. (AENT) at Buy
-
GenSight Biologics Announces Successful Completion of a Private Placement of Close to EUR 4 Million

